Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion type Assertion NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_head.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion description "[We conclude, that patients with type 2 diabetes and the 63bp deletion in the promoter of RAGE seem to be protected from diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion evidence source_evidence_literature NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion SIO_000772 15052533 NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion wasDerivedFrom befree-2016 NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.
- NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_assertion wasGeneratedBy ECO_0000203 NP437665.RAgoDpY5FJXo8xbJif9ZAUWMj-ro4rSGPD-mdAx508usg130_provenance.